Stockreport

60 Degrees Pharmaceuticals Receives FDA Orphan Drug Designation for Tafenoquine for Treatment of Patients with Acute Babesiosis [Yahoo! Finance]

60 Degrees Pharmaceuticals, Inc.  (SXTP) 
PDF 60 Degrees Pharmaceuticals recently announced it has entered into an agreement with Tufts Medical Center in Boston to conduct the world's first clinical trial evaluatin [Read more]